Qiming Venture Partners has led a $20 million round for New Horizon Health, a Chinese start-up that develops cancer screening technology, with participation from existing investors Legend Capital and SBCVC.
Founded in 2005, New Horizon has created a tool for screening stool samples and identifying changes in cell DNA that might be early signs of colon cancer. The company claims this is a more efficient detection...
Rob Kaplan is CEO of Singapore’s Circulate Capital, which is dedicated to reducing oceanic plastic pollution. Its $150 million debut fund is backed by the likes of Coca-Cola, PepsiCo, and Unilever
Australia’s Blackbird Ventures has raised A$500 million ($357 million) for its fourth fund and named Atlassian co-founder Mike Cannon-Brookes as chairman.
Yaoyanshe, a Chinese contract research organization (CRO) for novel drugs, has raised RMB600 million ($86 million) across two rounds in the past eight months.
MyGlamm, an online Indian cosmetics brand, has agreed to acquire POPxo, a women-focused content platform, for an undisclosed sum. Both companies have several VC backers.